Levoleucovorin
Back to searchMolecule Structure
Scientific Name
Levoleucovorin
Description of the Drug
Levoleucovorin is a folate analog used after high dose methotrexate for osteosarcoma, to reduce the toxic effects of folate analogs, and with 5-fluorouracil in palliative treatment of advanced metastatic colorectal cancer.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB11596
http://www.drugbank.ca/drugs/DB11596
Brand Name(s)
Khapzory
Company Owner(s)
Sandoz Inc, Novast Laboratories Ltd, Gland Pharma Ltd, Praxgen Pharmaceuticals Llc, Actavis Llc, Acrotech Biopharma Inc, Meitheal Pharmaceuticals Inc, Acrotech Biopharma Llc, Amneal Eu Ltd, Hikma Pharmaceuticals Usa Inc
Mechanism(s) Of Action
Not Available
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL571901 | SCHEMBL16946130 | |||||||
| Human Metabolome Database | HMDB0001562 | ||||||||
| DrugBank | DB11596 | ||||||||
| PubChem: Thomson Pharma | 49708539 | 16004520 | 14809717 | 15318605 | |||||
| PubChem | 135398559 | ||||||||
| NMRShiftDB | 60020503 | ||||||||
| Nikkaji | J185.512C | ||||||||
| PDBe | FFO | ||||||||
| BindingDB | 286 | ||||||||
| EPA CompTox Dashboard | DTXSID4023204 | ||||||||
| DrugCentral | 4384 | ||||||||
| Metabolights | MTBLC63606 | ||||||||
| Brenda | 120752 | 93399 | 1611 | 43539 | 120755 | 16045 | 17545 | 12733 | 247162 |
| rxnorm | LEVOLEUCOVORIN | KHAPZORY | LEVOLEUCOVORIN CALCIUM | ||||||
| ChEBI | 63606 | ||||||||
| ZINC | ZINC000009212427 |
